A comprehensive pan-cancer investigation of GPAA1 expression revealed consistently elevated mRNA levels across multiple malignancies, with CRC exhibiting particularly prominent upregulation (p < 0.05) upon integration of TCGA and GTEx datasets (Figure 2A). This evidence concerns the gene GPAA1 and colorectal carcinoma.